FICO UK Research Finds Fraud Protection Is a Bank’s Secret Advantage
Report on Fraud, Identity and Digital Banking reveals that good fraud strategies are the secret weapon to win and retain customers – as long as checks don’t... Read more.
Arcitecta Honored for Advanced Data Management Solution that Delivers High-speed File Transfers over Vast Distances and High Latency Networks
Mediaflux Livewire Named “Most Complete Architecture” by the International Data Mover Challenge at SCA24 MELBOURNE, Australia & SYDNEY–(BUSINESS WIRE)–#SCA24—Arcitecta,... Read more.
OPEX® Corporation Will Demonstrate its Advanced Warehouse Automation Technology at LogiMAT 2024, Including its Newest Solution Launching This March
MOORESTOWN, N.J.–(BUSINESS WIRE)–OPEX® Corporation, a global leader in Next Generation Automation for almost 50 years, will showcase its advanced Warehouse... Read more.
Arcitecta Unveils New Capabilities for Cross-Global Collaboration, Allowing Customers to Focus on the Value of Data, Not Its Management
Cutting-edge Data Management Software Provider Solves the Problems of Large-scale Data Transmission over Slow, Undependable Network Connections with the Most Complete... Read more.
Biocytogen and Gilead Enter Into a Multi-Target Antibody Collaboration Agreement
BEIJING–(BUSINESS WIRE)–#Antibody–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces an antibody evaluation... Read more.
Meta’s Bully Tactics Attempt to Remove Threads Software Limited Trademark Protections
LONDON–(BUSINESS WIRE)–Meta through its UK lawyers Bird & Bird is attempting to revoke the trademark protections of UK software company Threads Software... Read more.
Gary Pettit Appointed CEO of Sigma Broking
Vastly experienced financial services professional to lead international broking business LONDON–(BUSINESS WIRE)–Sigma Broking Ltd, the international... Read more.
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Application based on results from the TROPION-Lung01 phase 3 trial If approved, Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan may be the first TROP2... Read more.
Almirall Licenses an Anti-IL-21 Monoclonal Antibody From Novo Nordisk to Develop It as a First-in-Class Agent in Dermatology
Almirall obtains exclusive global rights to develop and commercialize NN-8828 for use in several fields, including immune inflammatory dermatological diseases NN-8828... Read more.
Almirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology business
Almirall’s Full-Year 2023 Results Company revenue growth driven by the strong performance of the European Dermatology business (+17% year-on-year) based on key... Read more.